Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapy of Infliximab and Immunosuppressives for Pediatric Crohn's Disease
NCT05043870Phase 4Recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Oct 2022
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of azathioprine, methotrexate in Crohn's disease, sponsored by Children's Hospital of Fudan University. Started Oct 2022; status: recruiting.
02
Drugs
azathioprinemethotrexate
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT05043870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05043870.